We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $1.94B
1-Year Est. Return 20.77%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+20.77%
3 Year Est. Return
+69.82%
5 Year Est. Return
+88.03%
10 Year Est. Return
+482.02%
AUM
$1.58B
AUM Growth
+$211M
Cap. Flow
-$124M
Cap. Flow %
-7.86%
Top 10 Hldgs %
30.44%
Holding
217
New
13
Increased
37
Reduced
43
Closed
20

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.8M
2
KEYS icon
Keysight
KEYS
+$22.1M
3
ELF icon
e.l.f. Beauty
ELF
+$6.87M
4
PGNY icon
Progyny
PGNY
+$6.62M
5
BDX icon
Becton Dickinson
BDX
+$6.58M

Top Sells

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$22.1M
2
LHX icon
L3Harris
LHX
+$18.4M
3
EPD icon
Enterprise Products Partners
EPD
+$7.07M
4
HQY icon
HealthEquity
HQY
+$5.87M
5
PAYO icon
Payoneer
PAYO
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 24.63%
2 Healthcare 16.24%
3 Industrials 12.57%
4 Consumer Staples 8.27%
5 Financials 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
76
IBM
IBM
$224B
$1.66M 0.11%
10,130
JNJ icon
77
Johnson & Johnson
JNJ
$625B
$1.63M 0.1%
10,429
CYTK icon
78
Cytokinetics
CYTK
$10.4B
$1.45M 0.09%
+17,340
New +$628K
BRK.B icon
79
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.34M 0.08%
3,746
HD icon
80
Home Depot
HD
$355B
$1.13M 0.07%
3,260
XOM icon
81
ExxonMobil
XOM
$634B
$1.08M 0.07%
10,842
ESS icon
82
Essex Property Trust
ESS
$18.5B
$1.01M 0.06%
4,055
NVDA icon
83
NVIDIA
NVDA
$5.42T
$925K 0.06%
18,680
+1,890
+11% +$87.6K
CRM icon
84
Salesforce
CRM
$158B
$763K 0.05%
2,898
ABBV icon
85
AbbVie
ABBV
$435B
$762K 0.05%
4,916
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$4.33T
$708K 0.05%
5,070
+55
+1% +$7.39K
WFC icon
87
Wells Fargo
WFC
$264B
$684K 0.04%
13,896
PLTR icon
88
Palantir
PLTR
$413B
$670K 0.04%
39,000
-15,761
-29% -$281K
XLK icon
89
State Street Technology Select Sector SPDR ETF
XLK
$123B
0
CATX icon
90
Perspective Therapeutics
CATX
$342M
$636K 0.04%
158,210
AKYA
91
DELISTED
Akoya BioSciences
AKYA
$616K 0.04%
126,131
MRK icon
92
Merck
MRK
$318B
$605K 0.04%
5,552
-95
-2% -$9.86K
COST icon
93
Costco
COST
$420B
$506K 0.03%
766
-4
-0.5% -$2.37K
HYS icon
94
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
0
LECO icon
95
Lincoln Electric
LECO
$15.4B
$478K 0.03%
2,200
ABT icon
96
Abbott
ABT
$187B
$441K 0.03%
4,010
ISTB icon
97
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
0
VOO icon
98
Vanguard S&P 500 ETF
VOO
$1.03T
0
UNH icon
99
UnitedHealth
UNH
$370B
$408K 0.03%
775
+11
+1% +$5.87K
DIS icon
100
Walt Disney
DIS
$181B
$328K 0.02%
3,630

Similar funds

Osterweis Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Osterweis Capital Management held 217 positions worth $1.58B, up 15% from $1.36B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Osterweis Capital Management withdrew a net $124M in Q4 2023, closing 20 positions and reducing 43 holdings. Its most notable exit was Avantor, an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Osterweis Capital Management opened a new position in Keysight worth $25.9M.

  • Osterweis Capital Management's largest Q4 2023 buy was Keysight: 163,052 shares worth $25.9M.
  • Osterweis Capital Management added most to Thermo Fisher Scientific in Q4 2023, an estimated $25.8M increase.
  • Osterweis Capital Management's biggest Q4 2023 reduction was L3Harris, cutting an estimated $18.4M.
  • Osterweis Capital Management fully exited Avantor in Q4 2023, selling an estimated $22.1M.
  • Osterweis Capital Management's ten largest holdings make up 30% of its $1.58B portfolio in Q4 2023.
  • Osterweis Capital Management opened 13 new positions and closed 20 in Q4 2023.
  • Osterweis Capital Management's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Osterweis Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.